Nanjing Other Current Liab vs Net Receivables Analysis

688580 Stock

30.79 0.15 0.49%

Nanjing Vishee financial indicator trend analysis is infinitely more than just investigating Nanjing Vishee Medical recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nanjing Vishee Medical is a good investment. Please check the relationship between Nanjing Vishee Other Current Liab and its Net Receivables accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Nanjing Vishee Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Other Current Liab vs Net Receivables

Other Current Liab vs Net Receivables Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nanjing Vishee Medical Other Current Liab account and Net Receivables. At this time, the significance of the direction appears to have strong contrarian relationship.

The correlation between Nanjing Vishee's Other Current Liab and Net Receivables is -0.59. Overlapping area represents the amount of variation of Other Current Liab that can explain the historical movement of Net Receivables in the same time period over historical financial statements of Nanjing Vishee Medical, assuming nothing else is changed. The correlation between historical values of Nanjing Vishee's Other Current Liab and Net Receivables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Current Liab of Nanjing Vishee Medical are associated (or correlated) with its Net Receivables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Receivables has no effect on the direction of Other Current Liab i.e., Nanjing Vishee's Other Current Liab and Net Receivables go up and down completely randomly.

Correlation Coefficient

-0.59

Relationship Direction	Negative
Relationship Strength	Very Weak

View All Relationships

Other Current Liab

Net Receivables

Most indicators from Nanjing Vishee's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nanjing Vishee Medical current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Nanjing Vishee Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

The current year's Tax Provision is expected to grow to about 16 M, whereas Selling General Administrative is forecasted to decline to about 96.7 M.

	2021	2022	2023	2024 (projected)
Gross Profit	321.6M	233.1M	331.7M	261.0M
Total Revenue	430.0M	321.6M	462.2M	355.7M

Gross Profit Total Revenue

Nanjing Vishee fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Total Liab	Deferred Long Term Liab	Net Invested Capital	Short Long Term Debt	Total Current Assets	Net Working Capital	Intangible Assets	Common Stock
Total Assets		-0.32	0.79	1.0	-0.85	1.0	0.97	0.76	0.99	0.73	0.43	0.83	-0.87	0.87	0.9	-0.3	0.91	0.56	0.75	0.94	1.0	-0.09	0.99	0.99	0.66	0.98
Other Current Liab	-0.32		-0.17	-0.32	0.5	-0.28	-0.33	-0.68	-0.21	-0.75	0.2	-0.65	0.1	-0.59	-0.51	-0.72	-0.17	-0.64	-0.38	-0.16	-0.32	0.47	-0.22	-0.22	-0.84	-0.4
Total Current Liabilities	0.79	-0.17		0.77	-0.45	0.77	0.85	0.75	0.75	0.72	0.09	0.66	-0.95	0.73	0.77	-0.33	0.97	0.7	0.96	0.72	0.77	0.45	0.76	0.73	0.66	0.78
Total Stockholder Equity	1.0	-0.32	0.77		-0.85	1.0	0.97	0.75	0.99	0.71	0.45	0.83	-0.86	0.86	0.89	-0.31	0.9	0.54	0.73	0.94	1.0	-0.11	0.99	0.99	0.65	0.98
Other Liab	-0.85	0.5	-0.45	-0.85		-0.84	-0.75	-0.61	-0.85	-0.67	-0.35	-0.77	0.56	-0.82	-0.78	0.11	-0.61	-0.48	-0.44	-0.86	-0.85	0.56	-0.85	-0.86	-0.64	-0.85
Net Tangible Assets	1.0	-0.28	0.77	1.0	-0.84		0.97	0.73	0.99	0.69	0.46	0.81	-0.85	0.84	0.89	-0.32	0.89	0.51	0.72	0.95	1.0	-0.1	0.99	0.99	0.61	0.98
Retained Earnings	0.97	-0.33	0.85	0.97	-0.75	0.97		0.78	0.94	0.78	0.46	0.88	-0.91	0.89	0.92	-0.28	0.93	0.66	0.82	0.87	0.97	0.06	0.94	0.94	0.69	0.96
Accounts Payable	0.76	-0.68	0.75	0.75	-0.61	0.73	0.78		0.67	0.82	-0.02	0.78	-0.68	0.74	0.78	0.27	0.75	0.67	0.86	0.64	0.75	0.0	0.68	0.66	0.88	0.77
Cash	0.99	-0.21	0.75	0.99	-0.85	0.99	0.94	0.67		0.64	0.48	0.77	-0.86	0.82	0.83	-0.42	0.88	0.45	0.67	0.95	0.99	-0.1	1.0	1.0	0.56	0.94
Non Current Assets Total	0.73	-0.75	0.72	0.71	-0.67	0.69	0.78	0.82	0.64		0.06	0.91	-0.69	0.94	0.85	0.15	0.72	0.95	0.8	0.56	0.72	-0.07	0.65	0.64	0.97	0.77
Non Currrent Assets Other	0.43	0.2	0.09	0.45	-0.35	0.46	0.46	-0.02	0.48	0.06		0.43	-0.34	0.32	0.22	-0.53	0.24	-0.04	-0.05	0.34	0.45	-0.05	0.48	0.49	-0.11	0.35
Other Assets	0.83	-0.65	0.66	0.83	-0.77	0.81	0.88	0.78	0.77	0.91	0.43		-0.73	0.96	0.84	0.0	0.72	0.79	0.69	0.65	0.83	-0.14	0.78	0.78	0.85	0.83
Long Term Debt	-0.87	0.1	-0.95	-0.86	0.56	-0.85	-0.91	-0.68	-0.86	-0.69	-0.34	-0.73		-0.78	-0.75	0.5	-0.98	-0.62	-0.87	-0.78	-0.86	-0.37	-0.87	-0.85	-0.6	-0.81
Net Receivables	0.87	-0.59	0.73	0.86	-0.82	0.84	0.89	0.74	0.82	0.94	0.32	0.96	-0.78		0.91	-0.09	0.8	0.86	0.74	0.74	0.86	-0.15	0.82	0.82	0.86	0.89
Common Stock Shares Outstanding	0.9	-0.51	0.77	0.89	-0.78	0.89	0.92	0.78	0.83	0.85	0.22	0.84	-0.75	0.91		-0.03	0.83	0.77	0.8	0.83	0.89	-0.14	0.84	0.83	0.78	0.96
Non Current Liabilities Total	-0.3	-0.72	-0.33	-0.31	0.11	-0.32	-0.28	0.27	-0.42	0.15	-0.53	0.0	0.5	-0.09	-0.03		-0.4	0.13	-0.06	-0.38	-0.3	-0.38	-0.41	-0.41	0.33	-0.19
Inventory	0.91	-0.17	0.97	0.9	-0.61	0.89	0.93	0.75	0.88	0.72	0.24	0.72	-0.98	0.8	0.83	-0.4		0.64	0.91	0.85	0.89	0.29	0.89	0.87	0.64	0.88
Other Current Assets	0.56	-0.64	0.7	0.54	-0.48	0.51	0.66	0.67	0.45	0.95	-0.04	0.79	-0.62	0.86	0.77	0.13	0.64		0.78	0.4	0.54	0.09	0.47	0.45	0.88	0.63
Total Liab	0.75	-0.38	0.96	0.73	-0.44	0.72	0.82	0.86	0.67	0.8	-0.05	0.69	-0.87	0.74	0.8	-0.06	0.91	0.78		0.65	0.73	0.37	0.68	0.66	0.79	0.77
Deferred Long Term Liab	0.94	-0.16	0.72	0.94	-0.86	0.95	0.87	0.64	0.95	0.56	0.34	0.65	-0.78	0.74	0.83	-0.38	0.85	0.4	0.65		0.94	-0.17	0.95	0.95	0.5	0.93
Net Invested Capital	1.0	-0.32	0.77	1.0	-0.85	1.0	0.97	0.75	0.99	0.72	0.45	0.83	-0.86	0.86	0.89	-0.3	0.89	0.54	0.73	0.94		-0.11	0.99	0.99	0.65	0.98
Short Long Term Debt	-0.09	0.47	0.45	-0.11	0.56	-0.1	0.06	0.0	-0.1	-0.07	-0.05	-0.14	-0.37	-0.15	-0.14	-0.38	0.29	0.09	0.37	-0.17	-0.11		-0.09	-0.12	-0.13	-0.15
Total Current Assets	0.99	-0.22	0.76	0.99	-0.85	0.99	0.94	0.68	1.0	0.65	0.48	0.78	-0.87	0.82	0.84	-0.41	0.89	0.47	0.68	0.95	0.99	-0.09		1.0	0.57	0.95
Net Working Capital	0.99	-0.22	0.73	0.99	-0.86	0.99	0.94	0.66	1.0	0.64	0.49	0.78	-0.85	0.82	0.83	-0.41	0.87	0.45	0.66	0.95	0.99	-0.12	1.0		0.56	0.94
Intangible Assets	0.66	-0.84	0.66	0.65	-0.64	0.61	0.69	0.88	0.56	0.97	-0.11	0.85	-0.6	0.86	0.78	0.33	0.64	0.88	0.79	0.5	0.65	-0.13	0.57	0.56		0.7
Common Stock	0.98	-0.4	0.78	0.98	-0.85	0.98	0.96	0.77	0.94	0.77	0.35	0.83	-0.81	0.89	0.96	-0.19	0.88	0.63	0.77	0.93	0.98	-0.15	0.95	0.94	0.7

Click cells to compare fundamentals

Nanjing Vishee Account Relationship Matchups

Nanjing Vishee fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	404.2M	1.5B	1.6B	1.7B	1.8B	1.2B
Other Current Liab	99.1M	94.0M	75.3M	2.1M	1.3M	1.2M
Total Current Liabilities	141.6M	128.7M	103.9M	129.2M	151.7M	129.0M
Total Stockholder Equity	249.2M	1.4B	1.5B	1.5B	1.6B	1.0B
Net Tangible Assets	230.0M	1.4B	1.5B	1.4B	1.6B	885.8M
Retained Earnings	178.7M	272.5M	378.5M	349.1M	438.4M	284.0M
Accounts Payable	10.5M	9.9M	9.3M	19.7M	18.0M	13.1M
Cash	244.4M	1.4B	1.4B	1.2B	1.2B	892.2M
Non Current Assets Total	121.9M	121.6M	204.4M	365.0M	551.2M	578.8M
Non Currrent Assets Other	1.3M	191.8K	71.9M	6.1M	1.4M	1.3M
Other Assets	640.7K	1.3M	3.4M	85.4M	98.2M	103.1M
Net Receivables	1.6M	12.9M	24.3M	21.1M	36.6M	38.5M
Non Current Liabilities Total	7.7M	776.2K	1.8M	26.4M	27.6M	16.3M
Inventory	31.5M	37.1M	30.4M	34.8M	39.9M	32.7M
Other Current Assets	4.8M	1.1M	3.0M	4.3M	12.6M	13.2M
Total Liab	149.4M	129.5M	105.7M	155.7M	179.3M	145.3M
Deferred Long Term Liab	33.9K	294.8K	1.1M	768.8K	884.1K	528.3K
Net Invested Capital	263.2M	1.4B	1.5B	1.5B	1.6B	1.1B
Short Long Term Debt	10M	1.1M	1.2M	1.2M	1.1M	1.0M
Total Current Assets	282.3M	1.4B	1.4B	1.3B	1.3B	950.4M
Net Working Capital	140.7M	1.3B	1.3B	1.2B	1.1B	821.4M
Intangible Assets	19.2M	20.0M	18.8M	106.5M	120.6M	126.6M
Property Plant Equipment	102.5M	101.3M	98.3M	100.3M	115.3M	103.9M

Currently Active Assets on Macroaxis

TITAN	Titan Company Limited
U	Unity Software
PAYC	Paycom Soft
HBI	Hanesbrands
STLD	Steel Dynamics

Other Information on Investing in Nanjing Stock

Balance Sheet is a snapshot of the financial position of Nanjing Vishee Medical at a specified time, usually calculated after every quarter, six months, or one year. Nanjing Vishee Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Nanjing Vishee and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Nanjing currently owns. An asset can also be divided into two categories, current and non-current.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Nanjing Other Current Liab vs Net Receivables Analysis

Other Current Liab vs Net Receivables

Other Current Liab vs Net Receivables Correlation Analysis

Correlation Coefficient

Other Current Liab

Net Receivables

Nanjing Vishee fundamental ratios Correlations

Nanjing Vishee Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Nanjing Vishee fundamental ratios Accounts

Currently Active Assets on Macroaxis

Other Information on Investing in Nanjing Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Assets
Net Invested Capital	+ 1.0	Total Assets
Net Tangible Assets	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Total Stockholder Equity
Net Invested Capital	+ 1.0	Net Tangible Assets

Inventory	- 0.98	Long Term Debt
Long Term Debt	- 0.95	Total Current Liabilities
Long Term Debt	- 0.91	Retained Earnings
Total Current Assets	- 0.87	Long Term Debt
Total Liab	- 0.87	Long Term Debt
Long Term Debt	- 0.87	Total Assets